EP4017871
Kirtil-tengdrar veiruferjudreifing á alfa-sarkóglýkan og meðhöndlunin á vöðvakyrkingi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.8.2020EP published:
17.1.2024EP application number:
20765424.5
EP translation filed:
15.4.2024Grant published:
15.5.2024EPO information:
European Patent Register
Max expiry date:
20.8.2040Expiry date:
20.8.2026Next due date:
31.8.2026
Title in English:
ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHYLanguage of the patent:
English
Timeline
Today
21.8.2020EP application
17.1.2024EP Publication
15.4.2024Translation submitted
15.5.2024Registration published
20.8.2026Expires
Owner
Name:
Research Institute at Nationwide Children's HospitalAddress:
700 Children's Drive, Room W172,, Columbus, Ohio 43205, US
Inventor
Name:
RODINO-KLAPAC, LouiseAddress:
Grove City, OH 43123, US
Name:
GRIFFIN, DanielleAddress:
Winchester, OH 43110, US
Name:
MENDELL, Jerry, R.Address:
Columbus, OH 43235, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962889749 PDate:
21.8.2019Country:
US
Number:
202063014934 PDate:
24.4.2020Country:
US
Number:
202063022843 PDate:
11.5.2020Country:
US
Classification
Categories:
C12N 15/86, C07K 14/47, A61K 48/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 9.7.2024
Expires: 20.8.2025
Payer: Árnason Faktor ehf.
Number: 5
Paid: 9.7.2024
Expires: 20.8.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 13.8.2025
Expires: 20.8.2026
Payer: Árnason Faktor ehf.